ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

March 5, 1993

Breast Cancer Family History Doesn’t Increase Risk Of Ovarian Cancer, Study Says

September 30, 2005

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

As Shutdown Nears, House Republicans Press For Deeper Cuts and Repeal of Obamacare

September 13, 2013